Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid arthritis in the elderly.

C P Mavragani1, H M Moutsopoulos

  • 1Department of Pathophysiology, School of Medicine, National University of Athens, Greece. hmoutsop@dh.uoa.gr

Experimental Gerontology
|August 5, 1999
PubMed
Summary

Late-onset rheumatoid arthritis (LORA) in patients over 60 differs from younger-onset disease (YORA) in presentation and immunogenetics. Greek LORA patients show similarities to younger counterparts, with standard treatments requiring caution in the elderly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.

Journal of autoimmunity·2021
Same author

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.

Seminars in arthritis and rheumatism·2020
Same author

West Nile Virus infection triggering autoimmune encephalitis: Pathophysiological and therapeutic implications.

Clinical immunology (Orlando, Fla.)·2019
Same author

Severe osteoporosis in a premenopausal woman.

Scandinavian journal of rheumatology·2019
Same author

Evolution from one autoimmune disorder to another. Epitope spreading?

Scandinavian journal of immunology·2018
Same author

The oral mucosa: A barrier site participating in tissue-specific and systemic immunity.

Oral diseases·2018

Area of Science:

  • Rheumatology
  • Immunology
  • Geriatric Medicine

Background:

  • Late-onset rheumatoid arthritis (LORA), defined as onset over 60 years, presents distinct clinical and immunogenetic characteristics compared to young-onset rheumatoid arthritis (YORA).
  • Understanding these differences is crucial for accurate diagnosis and effective management in the elderly population.

Purpose of the Study:

  • To delineate the specific features of LORA, including its clinical presentation, immunogenetic associations, and prognostic factors.
  • To compare LORA characteristics in Greek patients with those reported in younger populations.

Main Methods:

  • Comparative analysis of clinical and serological data between LORA and YORA patient cohorts.
  • Review of immunogenetic associations and prognostic indicators in LORA.

Related Experiment Videos

  • Evaluation of Greek LORA patient data against international findings.

    • Main Results:

    • LORA exhibits a more balanced sex distribution, abrupt onset, prominent large joint involvement, and fewer extra-articular manifestations than YORA.
    • Differences in rheumatoid factor (RF) and C-reactive protein (CRP) positivity exist between the age groups.
    • Absence of RF and presence of pitting edema are favorable prognostic signs in LORA.
    • Greek LORA patients do not significantly differ from their younger counterparts.

    Conclusions:

    • LORA represents a distinct subset of rheumatoid arthritis with unique epidemiological and clinical profiles.
    • Standard therapeutic approaches, including disease-modifying drugs and low-dose prednisone, are employed but require careful consideration in elderly patients due to potential comorbidities and altered drug metabolism.